Are there plans to conduct AIDS vaccine trials in India?
India’s first-ever clinical trial of a preventive AIDS vaccine began in February 2005 at the National AIDS Research Institute (NARI) in Pune, Maharashtra, after obtaining all ethical and regulatory approvals from the Government of India. The vaccine candidate being tested for safety and imunogencity at NARI is tgAAC09 (AAV). The second Phase I trial is scheduled to begin shortly at the Tuberculosis Research Centre (TRC) in Chennai, Tamil Nadu. The approval process for the second candidate,TBC-M4 (MVA), to be tested at TRC is also complete..